In focus · trending topic

Antibiotic resistance

58 stories · following the connections

Accelerate Diagnostics Joins Sepsis Alliance in Global #GivingTuesday Movement to Raise Awareness of Sepsis as Medical Emergency

By Nasdaq OMXNov 27, 2017, 11:27 PM UTC

Accelerate Diagnostics Welcomes Dr. Charles Watts to its Board of Directors

By Nasdaq OMXNov 16, 2017, 5:06 PM UTC

Accelerate Diagnostics to Present at the 29th Annual Piper Jaffray Healthcare Conference in New York City

By Nasdaq OMXNov 15, 2017, 1:31 PM UTC

Melinta Therapeutics Reports First Patient Treated in Phase 2 Study of Topical Radezolid for Treatment of Acne

By Nasdaq OMXNov 13, 2017, 12:00 PM UTC

Accelerate Diagnostics reports Q3 2017 financial results

By Nasdaq OMXNov 2, 2017, 8:01 PM UTC

Melinta Therapeutics Announces FDA Clearance of Antimicrobial Susceptibility Tests Concurrent with Baxdela Launch in the United States

By Nasdaq OMXOct 30, 2017, 12:01 PM UTC

Accelerate Diagnostics Schedules Call to Review Third Quarter 2017 Results for November 2nd

By Nasdaq OMXOct 16, 2017, 5:59 PM UTC

Melinta Therapeutics’ Topical Radezolid Well Tolerated in Phase 1 Study for Treatment of Acne

By Nasdaq OMXOct 10, 2017, 12:00 PM UTC